Oxycodone
Epidermolysis Bullosa Simplex
University Hospital, ToulouseSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Epidermolysis Bullosa Simplex cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE University Hospital, Toulouse | Phase 2/3 | B |
PRILOCAINE University Hospital, Toulouse | Phase 2/3 | B |
(±)-2-(2-(4-(P-CHLORO-.ALPHA.-PHENYLBENZYL)-1-PIPERAZINYL)ETHOXY)ETHANOL University Hospital, Toulouse | Phase 2/3 | CCC |
Same molecule, other indications
Oxycodone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →